7keto-stigmasterol and 7keto-cholesterol induce differential proteome changes to intestinal epitelial (Caco-2) cells

Food and Chemical Toxicology

Volumn 84, Issue , 2015, Pages 29-36

  Laparra, J M ^a   Alfonso Garcia A ^b   Alegria A ^b   Barbera R ^b   Cilla, A ^b  

^a UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

7keto cholesterol; 7keto stigmasterol; Caco 2 cells; Oxysterols; Proteome

Indexed keywords

7 KETO STIGMASTEROL; 7 OXOCHOLESTEROL; APOLIPOPROTEIN E; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; PHYTOSTEROL; PROTEIN BCL 2; RETINOIC ACID BINDING PROTEIN; SUPEROXIDE DISMUTASE; UBIQUITIN CONJUGATING ENZYME E2; UNCLASSIFIED DRUG; 7-KETOCHOLESTEROL; 7-KETOSTIGMASTEROL; CHOLESTEROL DERIVATIVE; OXIDIZING AGENT; PROTEOME; STIGMASTEROL;

ARTICLE; CACO 2 CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSKELETON; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LIPID HOMEOSTASIS; MACROPHAGE; PRINCIPAL COMPONENT ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; ANALOGS AND DERIVATIVES; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTESTINE CELL; METABOLISM; PEPTIDE MAPPING;

CACO-2 CELLS; ENTEROCYTES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; KETOCHOLESTEROLS; OXIDANTS; PEPTIDE MAPPING; PRINCIPAL COMPONENT ANALYSIS; PROTEOME; RNA, MESSENGER; STIGMASTEROL;

EID: 84938677296     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2015.06.021     Document Type: Article

References (47)

1. Alemany L., Laparra J.M., Barberá R., Alegría A. Evaluation of the cytotoxic effect of 7keto-stigmasterol and 7keto-cholesterol in human intestinal (Caco-2) cells. Food Chem. Toxicol. 2012, 50:3106-3113.
2. Alemany L., Laparra J.M., Barberá R., Alegría A. Relative expression of cholesterol transport-related proteins and inflammation markers through the induction of 7-ketosterol-mediated stress in Caco-2 cells. Food Chem. Toxicol. 2013, 56:247-253.
3. Alemany L., Barbera R., Alegría A., Laparra J.M. Plant sterols from foods in inflammation and risk of cardiovascular disease: a real threat?. Food Chem. Toxicol. 2014, 69:140-149.
4. Alex S., Liechtenstein L., Djik W., Mensink R.P., Tan N.S., Kersten S. Angptl4 is produced by entero-endocrine cells in the human intestinal tract. Histochem Cell Biol. 2013, 141(4):383-391.
5. Alfonso-García A., Cilla A., Barberá R., Alegría A. Evaluation of the cytotoxicity of cholesterol oxides in human colon cancer Caco-2 cells. Univ. J. Food Nutr. Sci. 2014, 2:27-32.
6. Bang H.J., Arakawa C., Takada M., Sato M., Imaizumi K. A comparison of the potential unfavourable effects of oxycholesterol and oxyphytosterol in mice: different effects on cerebral 24S-hydroxycholesterol and serum. Biosci. Biotechnol. Biochem. 2008, 72:3128-3133.
7. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000, 1:11-21.
8. Bordeleau F., Myrand Lapierre M.E., Sheng Y., Marceau N. Keratin 8/18 regulation of cell stiffness-extracellular matrix interplay through modulation of Rho-mediated actin cytoskeleton dynamics. PLoS One 2012, 7:e38780.
9. Brown A.J., Jessup W. Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol. Asp. Med. 2009, 30:111-122.
10. Corbin R.W., Paliy O., Yang F., Shabanowitz J., Platt M., Lyons C.E., Root K., McAuliffe J., Jordan M.I., Kustu S., Soupene E., Hunt D.F. Toward a protein profile of Escherichia coli: comparison to its transcription profile. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9232-9237.
11. Cubedo J., Padró T., Cinca J., Mata P., Alonso R., Badimon L. Retinol-binding protein 4 levels and susceptibility to ischaemic events in men. Eur. J. Clin. Invest. 2014, 44:266-275.
12. de Wit M., Kant H., Piersma S.R., Pham T.V., Mongera S., van Berkel M., Boven E., Pontén F., Meijer G.A., Jimenez C.R., Fijneman R.J.A. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling. J. Proteomics 2014, 99:26-39.
13. Grandgirard A., Demaison-Meloche J., Cordelet C., Demaison L. Incorporation of oxyphytosterols in tissues of hamster. Reprod. Nutr. Dev. 2004, 44:599-608.
14. Hoffmann E., Dittrich-Breiholz O., Holtmann H., Kracht M. Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 2002, 72:847-855.
15. Hovenkamp E., Demonty I., Plat J., Lütjohann D., Mensink R.P., Trautwein E.A. Biological effects of oxidized phytosterols: a review of the current knowledge. Prog. Lipid Res. 2008, 47:37-49.
16. Ishihama Y. Proteomic LC-MS systems using nanoscale liquid chromatography with tandem mass spectrometry. J. Chromatogr. A 2005, 1067:73-83.
17. Ishihama Y., Oda Y., Tabata T., Sato T., Nagasu T., Rappsilber J., Mann M. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 2005, 4:1265-1272.
18. Janumyan Y.M., Sansam C.G., Chattopadhyay A., Cheng N., Soucie E.L., Penn L.Z., Andrews D., Knudson C.M., Yang E. Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J. 2003, 22:5459-5470.
19. Kohan A.B. Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease. Curr. Opin. Endocrinol. Diabetes Obes. 2015, 22:119-125.
20. Lenaerts K., Bouwman F.G., Lamers W.H., Renes J., Mariman E.C. Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics 2007, 3:80-91.
21. Leonarduzzi G., Gamba P., Gargiulo S., Biasi F., Poli G. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Free Radic. Biol. Med. 2012, 52:19-34.
22. Liang Y.T., Wong W.T., Guan L., Tian X.Y., YingMa K., Huang Y., Chen Z.Y. Effect of phytosterols and their oxidation products on lipoprotein profiles and vascular function in hamster fed a high cholesterol diet. Atherosclerosis 2011, 219:124-133.
23. Lichtenstein L., Serhan N., Espinosa-Delgado S., Fabre A., Annema W., Tietge U.J., Robaye B., Boyenaems J.M., Laffargue M., Perret B., Martinez L.O. Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport. Cardiovasc. Res. 2015, 106(2):314-323. 10.1093/cvr/cvv109.
24. Lin C.Y., Huo C., Kuo L.K., Hiipakka R.A., Jones R.B., Lin H.P., Hung Y., Su L.C., Tseng J.C., Kuo Y.Y., Wang Y.L., Fukui Y., Kao Y.H., Kokontis J.M., Yeh C.C., Chen L., Yang S.D., Fu H.H., Chen Y.W., Tsai K.K., Chang J.Y., Chuu C.P. Cholestane-3suppresses proliferation, migration, and invasion of human prostate cancer cells. PLoS One 2013, 8:e65734.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDC T method. Methods 2001, 25:402-408.
26. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell 1995, 83:841-850.
27. Marttinen M., Pajari A.M., Päivärinta E., Storvik M., Marttinen P., Nurmi T., Niku M., Piironen V., Mutanen M. Plant sterol feeding induces tumor formation and alters sterol metabolism in the intestine of Apc(Min) mice. Nutr. Cancer 2014, 66:259-269.
28. Mascia C., Maina M., Chiarpotto E., Leonarduzzi G., Poli G., Biasi F. Proinflammatory effect of cholesterol and its oxidation products on CaCo-2 human enterocyte-like cells: effective protection by epigallocatechin-3-gallate. Free Radic. Biol. Med. 2010, 49:2049-2057.
29. Murphy K.L., Kittrel F.S., Gay J.P., Jager R., Medina D., Rosen J.M. Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice. Oncogene 1999, 18:6597-6604.
30. Nguyen T.M., Sawyer J.K., Kelley K.L., Davis M.A., Rudel L.L. Cholesterol esterification by ACAT2 is essential for efficient intestinal cholesterol absorption: evidence from thoracic lymph duct cannulation. J. Lipid Res. 2012, 53:95-104.
31. Noy N. Signaling by retinol and its serum binding protein. Prostag. Leukot. Ess. 2015, 93:3-7.
32. O'Callaghan Y., McCarthy F.O., O'Brien N.M. Recent advances in phytosterol oxidation products. Biochem. Biophys. Res. Commun. 2014, 446:786-791.
33. Olivares M., Laparra M., Sanz Y. Oral administration of Bifidobacterium longum CECT 7347 modulates jejunal proteome in an in vivo gliadin-induced enteropathy animal model. J. Proteomics 2012, 77:310-320.
34. Rosklint T., Ohlsson B.G., Wiklund O., Noren K., Hulten L.M. Oxysterols induce interleukin-1beta production in human macrophages. Eur. J. Clin. Invest. 2002, 32:35-42.
35. Roussi S., Gossé F., Aoudé-Werner D., Zhang X., Marchioni E., Geoffroy P., Miesch M., Raul F. Mitochondrial perturbation, oxidative stress and lysosomal destabilization are involved in 7b-hydroxysitosterol and 7b-hydroxycholesterol triggered apoptosis in human colon cancer cells. Apoptosis 2007, 12:87-96.
36. Sánchez-Muñiz F.J. Metabolic and physiological effects of phytosterols consumption. Bioavailability of Micronutriens and Minor Dietary Compounds 2003, 83-94. Kerala, India. M.P. Vaquero, T. Garcia-Arias, A. Carbajal, F.J. Sánchez-Muñiz (Eds.).
37. Scholz B., Guth S., Engel K.H., Steinberg P. Phytosterol oxidation products in enriched foods: occurrence, exposure and biological effects. Mol. Nutr. Food Res. 2015, 10.1002/mnfr.201400922.
38. Schurink M., Kooi E.M., Hulzebos C.V., Kox R.G., Groen H., Heineman E., Bos A.F., Hulscher J.B. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS One 2015, 10:e0121336.
39. Soengas M.S., Capodieci P., Polsky D., Mora J., Esteller M., Opitz-Araya X., McCombie R., Herman J.G., Gerald W.L., Lazebnik Y.A., Cordón-Cardó C., Lowe S.W. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001, 409:207-211.
40. Spann N.J., Glass C.K. Sterols and oxysterols in immune cell function. Nat. Immunol. 2013, 14:893-900.
41. Straiger H.C., Haas J., Machann R., Werner M., Weisser F., Schick F., Machicao N., Stefan A., Fritsche H.U. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 2009, 58:579-589.
42. Sun H., Zhang X., Zhao L., Zhen X., Huang S., Wang S., He H., Liu Z., Xu N., Yang F., Qu Z., Ma Z., Zhang C., Zhang Y., Hu Q. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor. J. Cell. Mol. Med. 2015, 19:836-849.
43. Tones M.A., Sharif N.A., Hawthorne J.N. Phospholipid turnover during cell-cycle traverse in synchronous Chinese-hamster ovary cells Mitogenesis without phosphoinositide breakdown. Biochem. J. 1988, 249:51-56.
44. Tontonoz P., Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 2003, 17:985-993.
45. Vanmierlo T., Husche C., Schott H.F., Pettersson H., Lutjohann D. Plant sterol oxidation products - analogs to cholesterol oxidation products from plant origin?. Biochimie 2013, 53:726-735.
46. Vejux A., Lizard G. Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol. Asp. Med. 2009, 30:153-170.
47. Wang Y., Muneton S., Sjövall J., Jovanovic J.N., Griffiths W.J. The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron. J. Proteome Res. 2008, 7:1606-1614.